Newbridge Financial Services Group, Inc. Madrigal Pharmaceuticals, Inc. Transaction History
Newbridge Financial Services Group, Inc.
- $372 Million
- Q4 2024
A detailed history of Newbridge Financial Services Group, Inc. transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Newbridge Financial Services Group, Inc. holds 4,203 shares of MDGL stock, worth $1.42 Million. This represents 0.35% of its overall portfolio holdings.
Number of Shares
4,203Holding current value
$1.42 Million% of portfolio
0.35%Shares
3 transactions
Others Institutions Holding MDGL
# of Institutions
338Shares Held
22.7MCall Options Held
757KPut Options Held
960K-
Janus Henderson Group PLC London, X02.21MShares$745 Million0.36% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny2.04MShares$689 Million38.14% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.03MShares$684 Million9.12% of portfolio
-
Rtw Investments, LP New York, NY1.99MShares$672 Million10.03% of portfolio
-
Baker Bros. Advisors LP New York, NY1.97MShares$666 Million6.75% of portfolio
About MADRIGAL PHARMACEUTICALS, INC.
- Ticker MDGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,103,400
- Market Cap $5.77B
- Description
- Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...